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Overview of the Global Prevalence 




Takotsubo syndrome (TTS) is an acute and reversible abnormal condition of 
the heart also known as stress cardiomyopathy, apical ballooning syndrome, or 
broken heart syndrome. It is an uncommon disease that mostly occurs among 
Asians though studies have shown its occurrence in other parts of the world. The 
typical takotsubo syndrome patient has a unique circumferential left ventricular 
contraction abnormality that extends beyond a coronary artery supply territory and 
appears to follow the anatomical cardiac sympathetic innervation.
The syndrome predominantly affects postmenopausal women and is often 
preceded by severe emotional or physical stress. The high risk of misdiagnosis on 
account of the similar clinical presentation between acute coronary syndrome 
(ACS) and TTS patients makes it imperative to do a detailed diagnostic work up of 
suspected patients.
Diagnosis of TTS is made by elevation of cardiac enzymes, abnormal electrocar-
diogram (ECG), visualization of abnormal myocardial wall motion, and demonstra-
tion of normal coronary arteries. Often, cardiac wall motion abnormalities resolve 
in weeks, and therapy is only necessary in hemodynamic unstable patients and if 
severe complications, such as arrhythmias, heart failure, thromboembolism, cardiac 
arrest, and cardiac wall rupture, occur. A universally acceptable guideline on TTS is 
necessary for its early diagnosis and optimal management.
Keywords: prevalence, diagnostic criteria, takotsubo syndrome, acute coronary 
syndrome
1. Introduction
Takotsubo syndrome (TTS) also known as left ventricular apical ballooning 
syndrome (LVBS), transient apical ballooning, broken heart syndrome or stress 
cardiomyopathy is an acute and reversible wall motion abnormality classically of 
the left ventricular myocardium, commonly but not exclusively seen among the 
Asian population. Takotsubo syndrome was first diagnosed in Hiroshima City 
Hospital Japan, in 1983 [1]. Sato and Dote in 1990 and 1991 introduced the term 
takotsubo (tako = octopus, tsubo = a pot) to describe the left ventricular silhouette 
during systole in five patients presenting with clinical features of myocardial 
infarction but without obstructive coronary artery disease [2].
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(The syndrome is characterized by regional left ventricular wall motion abnor-
mality (LVWMA) with a peculiar circumferential pattern resulting in a conspicu-
ous ballooning of the left ventricle during systole as seen in Figure 1a and b. The 
LVWMA extends beyond a single coronary artery supply region and is reversible 
with almost complete resolution of ventricular dysfunction in hours to weeks 
depicted in Figure 1c and d). The LVWMA may be localized to the apical, midapical, 
midventricular, midbasal, or basal segments of the left ventricle [4].
However TTS gained international attention in the early 2000s, when the first 
diagnostic criteria: including apical dyskinesia/akinesia with basal hyperkinesia, 
absence of obstructive coronary artery disease (CAD) on coronary angiography, 
new electrocardiographic abnormalities, modest elevation in serum cardiac troponin 
in the absence of pheochromocytoma, and myocarditis, were published [5].
Recently, the Heart Failure Association of the European Society of Cardiology 
in a position statement from the task force on TTS introduced the terms primary 
and secondary TTS. They reported that “Acute cardiac symptoms are the primary 
reason for seeking medical care in primary TTS while in secondary TTS, the 
syndrome occurs in patients already hospitalized for a medical or surgical  
condition” [6].
Figure 1. 
Left ventriculography during the acute stage of takotsubo syndrome shows typical midapical ballooning during 
systole (a) diastole, (b) systole. Cardiac magnetic resonance imaging 4 days after left ventriculography shows 
complete normalization of the left ventricular function (c) diastole, (d) systole. The figure is reproduced with 
permission from Y-Hassan et al. [3].
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2. Global prevalence
The prevalence of TTS has been reported to be approximately 2% of all patients 
presenting with clinical manifestation of ACS and up to 10% if only women are 
considered [7]. More than 85% of the patients with TS are said to be postmeno-
pausal women (aged 65–70 years) thus suggesting a possible hormonal response 
[6]. In Western countries, there is a female-to-male ratio of 9:1 [8], in contrast, men 
are more affected than women, for unknown reasons in Japan [9]. The syndrome 
has also been reported in all age groups and even in children [6].
Since the introduction of the term takotsubo in 1990 [4], TTS has increasingly 
gained more recognition in almost all countries of the world. The syndrome has 
been reported in a variety of races, the incidence and prevalence are rising in the 
Western countries due to greater awareness and widespread access to early invasive 
coronary angiography, but the syndrome is infrequently seen among African and 
Hispanics descents which maybe be due to poor awareness of the disease [10].
Minhas et al. reported from study done among North American population 
almost 20 times increase in the incidence of TTS from 2006 to 2012 (Figure 2) [11]. 
Similarly, a study by Murugiah et al. showed that hospitalization rates for TTS are 
increasing, in that study the incidence of primary TTS increased from 2.3 to 7.1 hos-
pitalizations per 100,000 person-years in 2007 to 2012. The corresponding incidence 
for secondary TTS increased from 3.4 hospitalizations per 100,000 person-years in 
2007 to 10.3 in 2012 [12].
2.1 Pathogenesis/pathophysiology
The proposed mechanism for the pathogenesis and pathophysiology of TS are 
complex and multifactorial which include acute reversible myocardial ischemia 
resulting from multivessel coronary artery spasm, microvascular dysfunction, 
left ventricular outflow tract obstruction (LVOTO), blood-borne catecholamine 
induced myocardial toxicity, epinephrine-induced switch in the intracellular signal 
Figure 2. 
Trends in reported incidence of takotsubo syndrome from 2006 to 2012. Modified with permission from a table 
by Minhas et al. [11].
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trafficking from Gs (stimulatory) to Gi (inhibitory) protein signaling through 
the B2 adrenoreceptor (B2AR) and sympathetic nervous system hyperactivation 
including local cardiac sympathetic disruption and norepinephrine excess and 
spillover [6].
2.2 Clinical presentation
Patients with TTS can present with acute chest pain, dyspnea, and syncope. 
They may also be completely asymptomatic and diagnosis made based on incidental 
abnormal electrocardiographic (ECG) or imaging features [13]. Furthermore, a 
minority of TTS patients may present with symptoms due to complications such as 
heart failure, pulmonary edema, cardiogenic shock, cardiac arrest, or stroke [14]. 
Takotsubo syndrome is often known to be preceded by a stressor; usually emotional 
in females or physical in males though no stressor may be identified in up to 30% of 
cases [14].
A strong association of subarachnoid hemorrhage and status epilepticus with 
TTS as well as a less strong association with seizures, transient global amnesia, 
meningoencephalitis, migraine headache, intracerebral hemorrhage and ischemic 
stroke was reported by Morris et al. [15]. In order to detect triggers in some cases, 
it is mandatory to scrutinize the individual’s history for such events, often time 
relatives or close friends may need to be consulted in instances that patients are 
reluctant to talk about stressful events.
With the present Covid-19 pandemic it will not be unusual if there is a surge 
in the global incidence of TTS which could be as a result of, physical stressors: the 
direct impacts of the covid-19 infection on the heart and other organs of the body 
or emotional stressors: in form of emotional distress arising from direct or indirect 
effects of the covid 19 infection. Covid 19 infection have been associated with stress 
cardiomyopathy especially among postmenopausal females, Minhas et al. reported 
the case of a 58 year old female Caucasian who presented with symptoms of corona 
virus infection and subsequently developed mixed shock with echocardiography 
findings classic for TTS [16].
Morner and colleagues suggested that the presence of a preexisting subclinical 
cardiomyopathy may be a co-pathophysiological factor; they reported a patient with 
background hypertrophic cardiomyopathy (HCM) who developed heart failure with 
echocardiographic confirmed large left ventricular aneurysm after gastrointestinal 
surgery. Therefore, such background condition ought to be identified and monitored 
closely because it may impact negatively on the outcome of the syndrome. Thyroid 
dysregulation and pheochromocytoma are also known stressor in the pathogenesis 
of TTS [17, 18].
2.3 Imaging modalities
Transthoracic echocardiography (TTE): provides a quick method of demon-
strating the left ventricular wall-motion abnormalities which usually extend beyond 
the distribution of a single coronary artery. Typically seen in TTS is hypokinesis 
or akinesis of the apical- and mid-segment of the left ventricle (LV) with charac-
teristic hyperkinetic basal segment. Other variants include basal segment akinesia 
with midventricular and apical sparing, as well as the focal variant, characterized 
by focal wall motion abnormalities. Transthoracic echocardiography also helps in 
following up patients and assessing progress by estimating the LV ejection fraction 
(LVEF). Mean LVEF of affected patients are in the range of 20–49% [19].
Left ventricular ejection fraction though commonly assessed by echocardiog-
raphy, can also be estimated by means of cardiac magnetic resonance imaging 
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(CMRI), or left ventriculography. Cardiac MRI offers unique advantage of safety, 
detailed anatomical visualization, and tissue characterization data, CMRI is 
essential for the exclusion of other entities particularly myocarditis and myocardial 
infarction with nonobstructive coronary arteries (MINOCA) [20].
Cardiac MRI is increasingly being preferred as a diagnostic technique uniquely 
suited for diagnosing TTS by accurately identifying reversible injury to the myocar-
dium by the presence of inflammation/edema and the absence of necrosis/fibrosis, 
quantifying ventricular function as well as visualizing regional wall-motion abnor-
malities. Importantly cardiac MRI helps differentiate TTS which is characterized by 
absence of delayed gadolinium hyper-enhancement from myocardial infarction and 
myocarditis in which delayed enhancement occurs.
In 2011, CMR diagnostic criteria for TTS were established which includes:
1. The presence of wall motion abnormalities
2. Edema of dysfunctional segments on T2 weighted sequences
3. Absence of late gadolinium enhancement (LGE)
The absence of LGE suggests that there is no fibrosis or increased extracellular 
space. However, in some cases up to 9%, some spots of fibrosis are found, and these 
have been associated with worst prognosis [21].
Studies based on positron emission tomography (PET) and myocardial SPECT 
have shown a discrepancy between normal perfusion and reduced glucose utiliza-
tion in TTS, commonly known as “inverse flow metabolism mismatch”. In the acute 
phase, TTS may be clinically indistinguishable from acute MI but, by means of PET, 
it has been successfully distinguished from acute MI [22]. Undoubtedly, coronary 
angiography is essential for the diagnosis of TTS by demonstrating a completely 
normal coronary arteries or rarely noncritical stenosis. It’s important to note that 
left ventriculography is perhaps the best imaging modality for demonstrating the 
pathognomonic wall motion abnormalities and evaluating LV ejection fraction.
Data obtained from several registries including the international Takotsubo 
(InterTAK) Registry, a multicenter, prospective, retrospective, and observational 
study, which was conducted in more than 35 cardiovascular centers in 15 European 
countries, has enabled a diagnostic algorithm to be formulated. The diagnosis of TTS, 
which must be based on the absence of culprit coronary disease or presence of mild 
forms of coronary atherosclerosis. Therefore, TTS is gradually being better investi-
gated and understood, and the number of diagnoses is increasing, as evidenced in the 
disease being included in the recent 4th universal definition of myocardial infarction 
by the European Society of Cardiology (ESC) [23].
2.4 Electrocardiogram
Electrocardiogram (ECG) is important in making a diagnosis of TTS, ECG is 
very useful in differentiating TTS from is closest differential, acute myocardial 
infarction. Table 1 depicts the differences between the two conditions. ST-segment 
elevation and T-wave inversion are the commonest abnormalities seen on the initial 
ECG, which have been found to commonly involve the precordial leads and to be 
maximal in leads V2-V3. Unlike patients with ST-elevation myocardial infarction 
(STEMI) from left anterior descending (LAD) coronary artery occlusion, patients 
with TTS had significantly lower amplitude of ST-segment elevations. Similarly, 
T- wave inversions tend to occur in the days and weeks following presentation as 
the ST segments normalize, thus ECG cannot reliably differentiate TTS from other 
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conditions with ST segments elevation. Chest radiograph, which is readily available 
and affordable, though often normal may demonstrate pulmonary edema in patients 
with the syndrome.
2.5 Biochemical profiles of takotsubo syndrome
Serum troponin is usually positive in the acute phase, but its values tend to be 
low when compares with the extent of myocardial dysfunction. The troponin level 
in TTS is commonly believed to be lower than in acute myocardial infarction (MI), 
though the InterTAK Registry has shown no difference between the two conditions. 
On the contrary, the hs-TnT/CKMB ratio has been found to be significantly higher 
in TTS when compares with STEMI and NSTEMI [25].
Increased levels of serum NT-proBNP can be demonstrated during the course 
of TTS. Nef and colleagues found that serum levels of NT-proBNP on admission 
were correlated to the severity of post-TTS complications during hospitalization, 
the higher the serum levels of NT-proBNP were on admission, the more clinical 
complications such as pulmonary edema and malignant ventricular arrhythmia 
present [26].
Recently, a two-part International expert consensus document on Takotsubo 
syndrome was published, providing a detailed characterization of TTC that allows 
clinicians to understand this cardiac dysfunction with a multidisciplinary view. 
There have been several attempts to create effective diagnostic criteria for TTS. The 
most widely used since 2018 has been the European Society of Cardiology (ESC) 
International Takotsubo Diagnostic Criteria (InterTAK Diagnostic Criteria) [27], 
which implements a diagnostic algorithm and assigns a score to TTS. InterTAK 
Diagnostic Score considers the following variables and gives each one a specific 
score: female sex; emotional and physical stress; absent ST depression; psychiatric 
disorders; neurologic disorders; and QTc prolongation. If the score is ≤70 points, 
the probability of having TTS is intermediate or low, whereas a score ≥70 indicates a 
high probability (Table 2).
Coronary angiography and left ventriculography are indicated in patients 
with a low probability of TTS and suspicion of ACS, while in patients with a high 
score, transthoracic echocardiography (TTE) should be performed. Wall motion 
abnormalities on TTE helps to decide the next step; if the typical presentation 
with circumferential ballooning pattern is absent, coronary angiography with 
left ventriculography is the next choice. In normal coronaries and typical bal-
looning, myocarditis must be excluded. The algorithm includes some red flags of 
Takotsubo syndrome Acute anterior myocardial infarction
1.  ST-segment elevation is detectable on precordial 
leads V1–V4 and limb leads I and aVL.
1.  ST-segment elevation is mainly localized in 
V2–V5 leads and in limb leads II and aVR
2. Absence of reciprocal changes in inferior leads 2.  There is presence of reciprocal changes in lateral 
and inferior leads
3.  ST-segment elevation occurs more frequently  
in aVR
3.  ST-segment elevation occurs more frequently 
in V1
4. There is absence of Q-wave 4. There is presence of Q-wave
5. ST-segment depressions occur in 10% of cases 5. ST-segment depression occurs in 30% of cases
6.  Significantly lower amplitude of ST-segment 
elevation
6. Higher amplitude of ST-segment elevation
Table 1. 
Electrocardiographic differences between takotsubo syndrome and acute myocardial infarction [24].
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myocarditis (signs and symptoms of viral infection, elevated ESR and/or PCR, and 
pericardial effusion); in the presence of the above, myocarditis should be excluded 
by Cardiac MRI.
2.6 Treatment
Supportive treatment is mainly indicated in the acute phase while promptly 
diagnosing and treating complications appropriately. In mild cases, in addition 
to supportive treatment bisoprolol and aspirin may be considered. However, for 
patients with complications standard treatment for the complications should be 
commenced such as antiarrhythmic drugs for arrhythmias, anticoagulation for 
those with documented thrombus in the left ventricle or embolic phenomena or 
until resolution of LVWMA.
The suggested treatment in cardiogenic shock due to left ventricular outflow 
tract obstruction (LVOTO) is intravenous fluid and parenteral beta-blocker which 
increases cardiac filling and suppresses the basal hypercontractility thereby 
reducing LVOTO or phenylephrine if patient is intolerant to intravenous fluid and 
betablocker. In primary failure, venoarterial extracorporeal membrane oxygen-
ation, left ventricular assist device or levosimendan should be considered as bridge 
to recovery [28].
2.7 Complications
Though initially believed to be a benign condition, outcomes in patients with 
TTS can be influenced negatively owing to the various in-hospital complica-
tions that may arise as a result of electrical and hemodynamic instability, such as 
cardiac arrhythmias, cardiogenic shock, ventricular thrombus, pulmonary edema, 
ventricular septal defect, free-wall rupture and arterial thromboembolism. Male 
patients have been shown to have three times higher mortality rate due to major 
adverse cardiac and cerebrovascular events [27].
2.8 Prognosis of takotsubo syndrome
Takotsubo syndrome has been known to recur, recurrence rate varies 
widely between 1.5% and 6.1% during 6 years follow up period. Notably female 
patients showed higher recurrence rate of TTS compared to male [29, 30]. A 
significantly higher recurrence rate of 17.7% have been reported in patients with 
InterTak diagnostic score
Female sex 25 points
Emotional stress 24 points
Physical stress 13 points
No ST depression 12 points
Psychiatric disorders 11 points
Neurologic disorders 9 points
QTc prolongation 6 points
Score >70 points: high probability of TTS
Score ≤70 points: low/intermediate probability of TTS
Table 2. 
Diagnostic criteria used to distinguish takotsubo syndrome (TTS) from acute coronary syndrome (ACS).
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pheochromocytoma-triggered TTS [18]. While some studies reported more male 
mortality compared to female [31]. Patel et al. found in their analysis no significant 
sex difference in respect to overall mortality rates of TTS patients aged ≥50 years [32].
Battrawy et al. reported from the multicenter GEIST (German Italian Stress 
Cardiomyopathy) Registry a recurrence rate of 4% at a median follow-up of 
830 days among 749 patients. A variable TTS pattern at recurrence is common in 
up to 20% of recurrence cases. In this study it was observed that many patients that 
presented initially with involvement of only the left ventricle (LV), some years later 
developed right ventricular or biventricular involvement [30].
3. Conclusion
In conclusion, TTC is an acute and reversible cardiac disease, which commonly 
affects females of post-menopausal age and is often triggered by emotional or 
physical factors. Initially thought to be limited to the Asian population, it is also 
found in other parts of the world. This syndrome is associated with acute dysfunc-
tion of the central and autonomic nervous systems.
In order to better understand TTC, research on better diagnostic tools and thera-
peutic options need to be done. The recently published consensus document on TTS 
enhances clinical characterization of the syndrome and is hereby recommended.
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